Our aim in this study was to determine the effects of acute, ambient hyperglycemia and sodium‐glucose cotransporter‐2 (SGLT2) inhibition on plasma amino acid metabolism in patients with type 1 diabetes (T1D). The gene discussed is SLC5A2; the disease is type 1 diabetes mellitus.